Literature DB >> 28911268

Apathy, not depressive symptoms, as a predictor of semantic and phonemic fluency task performance in stroke and transient ischemic attack.

Keera N Fishman1, Andrea R Ashbaugh1, Krista L Lanctôt2, Megan L Cayley3, Nathan Herrmann4, Brian J Murray3, Michelle Sicard3, Karen Lien3, Demetrios J Sahlas5, Richard H Swartz3.   

Abstract

OBJECTIVES: This study examined the relationship between apathy and cognition in patients with cerebrovascular disease. Apathy may result from damage to frontal subcortical circuits causing dysexecutive syndromes, but apathy is also related to depression. We assessed the ability of apathy to predict phonemic fluency and semantic fluency performance after controlling for depressive symptoms in 282 individuals with stroke and/or transient ischemic attack.
METHOD: Participants (N = 282) completed the Phonemic Fluency Test, Semantic Fluency Test, Center for Epidemiologic Studies Depression Scale, and Apathy Evaluation Scale. A cross-sectional correlational design was utilized.
RESULTS: Using hierarchical linear regressions, apathy scores significantly predicted semantic fluency performance (β = -.159, p = .020), but not phonemic fluency performance (β = -.112, p = .129) after scaling scores by age and years of education and controlling for depressive symptoms. Depressive symptoms entered into the first step of both hierarchical linear regressions did not predict semantic fluency (β = -.035, p = .554) or phonemic fluency (β = -.081, p = .173). Apathy and depressive symptoms were moderately correlated, r(280) = .58, p < .001.
CONCLUSIONS: The results of this study are consistent with research supporting a differentiation between phonemic and semantic fluency tasks, whereby phonemic fluency tasks primarily involve frontal regions, and semantic fluency tasks involve recruitment of more extended networks. The results also highlight a distinction between apathy and depressive symptoms and suggest that apathy may be a more reliable predictor of cognitive deficits than measures of mood in individuals with cerebrovascular disease. Apathy may also be more related to cognition due to overlapping motivational and cognitive frontal subcortical circuitry. Future research should explore whether treatments for apathy could be a novel target for improving cognitive outcomes after stroke.

Entities:  

Keywords:  Cerebrovascular disorders; motivation; neuropsychological tests; neuropsychology; verbal behavior

Mesh:

Year:  2017        PMID: 28911268     DOI: 10.1080/13803395.2017.1371282

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  5 in total

1.  Association Between Behavioral Dysexecutive Syndrome and the Health-Related Quality of Life Among Stroke Survivors.

Authors:  Yannis Yan Liang; Lisha Wang; Ying Yang; Yangkun Chen; Vincent C T Mok; Gabor S Ungvari; Winnie C W Chu; Jong S Kim; Wai-Kwong Tang
Journal:  Front Psychiatry       Date:  2020-09-08       Impact factor: 4.157

2.  Prevalence and Clinical Correlates of Poststroke Behavioral Dysexecutive Syndrome.

Authors:  Wai Kwong Tang; Chieh Grace Lau; Yan Liang; Lisha Wang; Vincent Mok; Oi Yan Yannie Soo; Wai Hong Thomas Leung; Gabor S Ungvari; Shinichiro Uchiyama; Jong S Kim
Journal:  J Am Heart Assoc       Date:  2019-11-07       Impact factor: 5.501

3.  Motivated semantic control: Exploring the effects of extrinsic reward and self-reference on semantic retrieval in semantic aphasia.

Authors:  Nicholas E Souter; Sara Stampacchia; Glyn Hallam; Hannah Thompson; Jonathan Smallwood; Elizabeth Jefferies
Journal:  J Neuropsychol       Date:  2022-01-11       Impact factor: 2.276

Review 4.  Apathy after stroke: Diagnosis, mechanisms, consequences, and treatment.

Authors:  Jonathan Tay; Robin G Morris; Hugh S Markus
Journal:  Int J Stroke       Date:  2021-02-04       Impact factor: 5.266

5.  Using Virtual Reality to Improve Apathy in Residential Aged Care: Mixed Methods Study.

Authors:  Dimitrios Saredakis; Hannah Ad Keage; Megan Corlis; Tobias Loetscher
Journal:  J Med Internet Res       Date:  2020-06-26       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.